What is the best treatment for post herpetic neuralgia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Post-Herpetic Neuralgia

Start with gabapentin as first-line oral therapy, titrating from 300 mg on day 1 to 900 mg on day 3, then up to 1800-3600 mg/day in three divided doses, or use topical lidocaine 5% patches for localized pain, particularly in elderly patients. 1, 2, 3

First-Line Treatment Algorithm

Topical Therapy (Preferred for Elderly or Localized Pain)

  • Lidocaine 5% patches provide excellent efficacy (NNT = 2) with minimal systemic absorption, making them ideal for elderly patients or those with comorbidities. 1, 2
  • Apply patches for 12-24 hours directly on affected areas, delivering medication gradually over hours. 1
  • This approach avoids systemic side effects like somnolence and dizziness that are particularly problematic in older adults. 2

Oral Gabapentin (First-Line Systemic Therapy)

  • The American College of Physicians recommends gabapentin as first-line oral pharmacological treatment, with FDA-approved dosing starting at 300 mg on day 1,600 mg on day 2 (300 mg twice daily), and 900 mg on day 3 (300 mg three times daily). 1, 3
  • Titrate up to 1800-3600 mg/day in three divided doses as needed for pain relief. 1, 3
  • Efficacy is demonstrated across the 1800-3600 mg/day range, but no additional benefit is shown above 1800 mg/day. 1, 3
  • Maximum time between doses should not exceed 12 hours. 3
  • Pain reduction can be seen as early as Week 1 and is maintained throughout treatment. 3, 4

Tricyclic Antidepressants (Alternative First-Line)

  • Nortriptyline has excellent efficacy (NNT = 2.64) and is preferred over amitriptyline due to better tolerability with equivalent analgesic benefit. 1, 2
  • Start at 10-25 mg at bedtime and increase every 3-7 days to a final dose of 25-100 mg at bedtime. 1
  • Taking at bedtime minimizes daytime sedation effects. 1

Second-Line Treatments (If Inadequate Response to First-Line)

Pregabalin

  • Consider pregabalin if gabapentin provides inadequate response, with an NNT of 4.93. 1
  • Effective dose typically ranges from 150-600 mg/day in two divided doses. 1, 5
  • Pain reduction can occur as early as Week 1 and persists throughout treatment. 5

High-Concentration Capsaicin

  • Capsaicin 8% patch can provide pain relief for at least 12 weeks. 1, 2
  • Apply 4% lidocaine for 60 minutes before capsaicin application to minimize erythema and burning pain. 1, 2

Tramadol

  • Shows efficacy with an NNT of 4.76 as a second-line option. 1

Third-Line Treatments (When Single Agents Fail)

Combination Therapy

  • Combining morphine with gabapentin may be more effective when single agents provide inadequate relief, allowing for lower doses of each medication while providing additive effects. 1, 2

Opioids (Use with Caution)

  • Oxycodone, extended-release morphine, and methadone show efficacy (NNT = 2.67) but should not be used as first-line agents. 1, 2
  • Risks include pronociception, cognitive impairment, respiratory depression, endocrine/immunological changes, and potential for misuse and addiction. 1, 2

Special Population Considerations

Elderly Patients

  • Start gabapentin at 100-200 mg/day in elderly patients with gradual titration. 2
  • Topical lidocaine patches are particularly valuable due to minimal systemic effects. 2
  • Always adjust dose based on renal function to prevent toxicity. 2
  • Monitor closely for neurological side effects (somnolence, dizziness, confusion) that are particularly problematic in older adults. 2

Renal Impairment

  • For creatinine clearance 30-60 mL/min: reduce gabapentin to 200-700 mg/day in divided doses. 3
  • For creatinine clearance 15-30 mL/min: reduce to 200-700 mg once daily. 3
  • For creatinine clearance <15 mL/min: reduce to 100-300 mg once daily. 3
  • Patients on hemodialysis require supplemental post-dialysis dosing of 125-350 mg after each 4-hour session. 3

Common Pitfalls and Caveats

What NOT to Use

  • Lamotrigine is not recommended for PHN due to lack of convincing evidence of efficacy and risk of lamotrigine-associated rash. 1, 2

Monitoring Requirements

  • Monitor for gabapentin side effects including somnolence, dizziness, ataxia, peripheral edema, and infection. 1, 4
  • These side effects are common but usually tolerable. 4
  • Elderly patients are particularly susceptible to mental clouding and falls risk. 2

Dosing Errors to Avoid

  • Do not underdose gabapentin—400 mg/day is far below the effective range for neuropathic pain control. 6
  • Do not exceed 12 hours between gabapentin doses. 3
  • Do not use doses above 1800 mg/day expecting additional benefit, though they are safe and well-tolerated. 1, 3

Non-Pharmacological Adjuncts

  • Cognitive behavioral therapy (CBT), hypnosis, and physical/occupational therapy may be beneficial as adjunctive treatments. 1, 2

Treatment Duration

  • PHN may persist for months to years, and some patients require long-term treatment with no maximum duration specified in guidelines. 1
  • Periodic reassessment of continued therapy is recommended, as PHN may improve over time. 1

References

Guideline

Treatment Options for Post-Herpetic Neuralgia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Postherpetic Neuralgia in Elderly Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Acute Shingles Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.